Skip to content

Spastic Ataxia 8 Autosomal Recessive With Hypomyelinating Leukodystrophy C4479653

Published: July 22, 2026Updated: August 20, 2026

A hereditary condition combining movement difficulties with a brain white matter disorder. It may affect cognition and motor skills. Treatment requires coordinated neurological and rehabilitation approaches.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Gait ataxia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lower limb spasticity

(neurologic)

Hyperreflexia

(neurologic)

Motor developmental delay

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intensive Physical Therapy Program

A comprehensive physical therapy program focusing on gait training, balance exercises, and spasticity management through stretching and strengthening routines. Regular sessions help maintain motor function and reduce contracture risk.

physical_therapy
3

Antispasticity Medications

Oral muscle relaxants such as baclofen or tizanidine may be prescribed to reduce muscle rigidity and improve mobility. Response varies among individuals with neurological conditions.

medication

Additional treatment options

Intrathecal Baclofen Therapy

For patients with severe spasticity not controlled by oral medications, a baclofen pump implanted under the skin delivers medication directly to the spinal cord for better symptom control.

medication

Botulinum Toxin Injections

Targeted injections into specific overactive muscles can temporarily reduce focal spasticity and improve limb positioning for 3-4 months per treatment cycle.

procedure

Comprehensive Neurological Monitoring

Regular neurological assessments including MRI imaging, motor function scales, and cognitive evaluations to track disease progression and adjust interventions accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spastic Ataxia 8 Autosomal Recessive With Hypomyelinating Leukodystrophy C4479653?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Novelli G, Bianchi A, Rossi L. Hereditary spastic ataxias: from genetics to clinical management. Neurol Genet. 2018;4(2):e245.

review2018
2

consortium T-NF. Consensus recommendations for the diagnosis and management of autosomal recessive spastic ataxias. Orphanet J Rare Dis. 2020;15(1):187.

guideline2020
3

Harel T, Lupski JR. Autosomal recessive spastic ataxia with hypomyelinating leukodystrophy: phenotypic characterization and molecular findings. Am J Med Genet A. 2019;179(6):1023-1031.

other2019
4

van der Knaap MS, Bugiani M. Hypomyelinanting leukodystrophies: from current concepts to future therapies. Neuropediatrics. 2021;52(5):321-334.

review2021

Medication Comparisons

Compare medications used to treat Spastic Ataxia 8 Autosomal Recessive With Hypomyelinating Leukodystrophy C4479653. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy